Generics
Gilead expands global access to lenacapavir for HIV prevention
2 October 2024 - HIV medication company Gilead Sciences Inc (Nasdaq: GILD) announced on Wednesday that it has signed royalty-free voluntary licensing agreements with six generic manufacturers to incre...
CivicaScript names new president
18 September 2024 - CivicaScript, a Utah-based nonprofit company focused on bringing lower-cost generic medicines to US consumers, announced on Tuesday the appointment of Brent J Eberle, RPh, MBA as i...
Zydus Lifesciences signs licensing and supply agreement with Viwit Pharmaceuticals
16 September 2024 - India-based pharmaceutical company focused on manufacturing generic drugs Zydus Lifesciences Ltd. announced on Friday that its wholly owned subsidiary, Zydus Lifesciences Global FZ...
Hikma Pharmaceuticals extends KLOXXADO nasal spray shelf-life 8mg from 24 to 36 months
16 August 2024 - Hikma Pharmaceuticals PLC, a London-based, multinational pharmaceutical company, announced on Thursday that it has extended the shelf-life of KLOXXADO (naloxone HCl) nasal spray eight...
Sun Pharma's LEQSELVI 8mg tablets receive US FDA approval
29 July 2024 - India-based specialty generics company with a presence in specialty, generics, and consumer healthcare products Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) (Bloomberg: SUNP ...
Emmaus Life Sciences names new chief executive officer
24 July 2024 - Sickle cell disease treatment specialist Emmaus Life Sciences Inc (OTCMarkets: EMMA) announced on Tuesday the appointment of Willis C Lee as its new chief executive officer.Lee was prev...